| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9540 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2- | 0.5244 |
| P-glycoprotein Substrate | Substrate | 0.8019 |
| P-glycoprotein Inhibitor | Inhibitor | 0.7761 |
| Inhibitor | 0.9004 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.5954 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8074 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8587 |
| CYP450 2D6 Substrate | Non-substrate | 0.7652 |
| CYP450 3A4 Substrate | Substrate | 0.7625 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8417 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.6358 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9043 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6584 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.5446 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5571 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7147 |
| Inhibitor | 0.6054 |
| AMES Toxicity | AMES toxic | 0.5582 |
| Carcinogens | Non-carcinogens | 0.7483 |
| Fish Toxicity | High FHMT | 0.9786 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9042 |
| Honey Bee Toxicity | Low HBT | 0.8301 |
| Biodegradation | Not ready biodegradable | 0.9827 |
| Acute Oral Toxicity | III | 0.6428 |
| Carcinogenicity (Three-class) | Non-required | 0.6220 |